150 related articles for article (PubMed ID: 31981447)
1. TRIM66 promotes malignant progression of prostate carcinoma through the JAK/STAT pathway.
Cao H; Gao R; Chen L; Feng Y
FEBS Open Bio; 2020 Apr; 10(4):515-524. PubMed ID: 31981447
[TBL] [Abstract][Full Text] [Related]
2. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
He T; Cui J; Wu Y; Sun X; Chen N
Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
[TBL] [Abstract][Full Text] [Related]
4. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
Fan W; Du F; Liu X
Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
[TBL] [Abstract][Full Text] [Related]
5. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
Lu J; Zhang L; Zhou H; Du Z; Zhang G
Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
[TBL] [Abstract][Full Text] [Related]
6. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of TRIM66 inhibits malignant behavior and epithelial-mesenchymal transition in non-small cell lung cancer.
Dai HY; Ma Y; Da Z; Hou XM
Pathol Res Pract; 2018 Aug; 214(8):1130-1135. PubMed ID: 29929749
[TBL] [Abstract][Full Text] [Related]
8. TRIM66 Promotes Malignant Progression of Non-Small-Cell Lung Cancer Cells via Targeting MMP9.
Xu Y; Yang Q; Fang Z; Tan X; Zhang M; Chen W
Comput Math Methods Med; 2022; 2022():6058720. PubMed ID: 35912155
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of TRIM66 in MDA-MB-468 triple negative breast cancer cell line suppresses proliferation and promotes apoptosis through EGFR signaling.
Zhang H; Zheng Y; Zhang Y
Pol J Pathol; 2021; 72(2):160-166. PubMed ID: 34706523
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA circCDK13 suppresses cell proliferation, migration and invasion by modulating the JAK/STAT and PI3K/AKT pathways in liver cancer.
Lin Q; Ling YB; Chen JW; Zhou CR; Chen J; Li X; Huang MS
Int J Oncol; 2018 Jul; 53(1):246-256. PubMed ID: 29658568
[TBL] [Abstract][Full Text] [Related]
11. MiR-23b functions as an oncogenic miRNA by downregulating Mcl-1S in lung cancer cell line A549.
Wang L; Hu Z; Guo Q; Yang L; Pang Y; Wang W
J Biochem Mol Toxicol; 2020 Jul; 34(7):e22494. PubMed ID: 32281274
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA LINC01234 promoted cell proliferation and invasion via miR-1284/TRAF6 axis in colorectal cancer.
Liao X; Zhan W; Zhang J; Cheng Z; Li L; Tian T; Yu L; Li R
J Cell Biochem; 2020 Oct; 121(10):4295-4309. PubMed ID: 31904146
[TBL] [Abstract][Full Text] [Related]
13. The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.
Tian X; Tao F; Zhang B; Dong JT; Zhang Z
IUBMB Life; 2018 Mar; 70(3):224-236. PubMed ID: 29389061
[TBL] [Abstract][Full Text] [Related]
14. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
[TBL] [Abstract][Full Text] [Related]
15. Qi Ling Inhibits Progression of Androgen-Independent Prostate Cancer via Negative Regulation of TRIM66/HP1γ/AR Axis.
Feng Y; Gao D; Cao H; Chen L
Complement Med Res; 2021; 28(6):492-500. PubMed ID: 34077947
[TBL] [Abstract][Full Text] [Related]
16. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
17. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.
Ogony J; Choi HJ; Lui A; Cristofanilli M; Lewis-Wambi J
Breast Cancer Res; 2016 Feb; 18(1):25. PubMed ID: 26897526
[TBL] [Abstract][Full Text] [Related]
18. HSPB8 facilitates prostate cancer progression via activating the JAK/STAT3 signaling pathway.
Zhang K; Yin W; Ma L; Liu Z; Li Q
Biochem Cell Biol; 2023 Feb; 101(1):1-11. PubMed ID: 36318825
[TBL] [Abstract][Full Text] [Related]
19. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.
Yang W; Qian Y; Gao K; Zheng W; Wu G; He Q; Chen Q; Song Y; Wang L; Wang Y; Gu P; Chen B; Zhai R
Carcinogenesis; 2021 Feb; 42(1):80-92. PubMed ID: 32459848
[TBL] [Abstract][Full Text] [Related]
20. Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway.
Ye J; Gao M; Guo X; Zhang H; Jiang F
Biomed Pharmacother; 2020 Jul; 127():110223. PubMed ID: 32413672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
